Hims & Hers Health, Inc. (HIMS) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Hims & Hers Health, Inc. (HIMS) Earnings Overview
As of June 21, 2026, Hims & Hers Health, Inc. (HIMS) reported trailing twelve-month net income of -$13M, reflecting -3.8% year-over-year growth. The company earned $-0.06 per diluted share over the past four quarters, with a net profit margin of 5.5%.
Looking at the long-term picture, HIMS's historical earnings data spans multiple years. The company achieved its highest annual net income of $128M in fiscal 2025, representing a new all-time high.
Hims & Hers Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including TDOC (-$171M net income, -7.9% margin), DOCS ($196M net income, 30.4% margin), OPRX ($7M net income, 4.7% margin), HIMS has outperformed on profitability metrics. Compare HIMS vs TDOC →
HIMS Earnings vs Peers
Earnings metrics vs comparable public companies
HIMS Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $128M | +1.8% | $106M | $0.51 | 5.5% | 4.5% |
| 2024 | $126M | +635.3% | $62M | $0.53 | 8.5% | 4.2% |
| 2023 | -$24M | +64.1% | -$29M | $-0.11 | -2.7% | -3.4% |
| 2022 | -$66M | +39.0% | -$69M | $-0.32 | -12.5% | -13.0% |
| 2021 | -$108M | -494.3% | -$115M | $-0.58 | -39.6% | -42.3% |
| 2020 | -$18M | +74.9% | -$15M | $-0.51 | -12.2% | -10.2% |
| 2019 | -$72M | - | -$74M | $-2.07 | -87.3% | -90.1% |
Download Data
Export HIMS earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HIMS — Frequently Asked Questions
Quick answers to the most common questions about buying HIMS stock.
What is HIMS earnings per share (EPS)?
HIMS trailing twelve-month (TTM) diluted EPS is $-0.06, reflecting -3.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is Hims & Hers Health, Inc.'s net income?
Hims & Hers Health, Inc. (HIMS) trailing twelve-month net income is $-13M as of 2025. Earnings declined -3.8% year-over-year. Hims & Hers Health, Inc. has been profitable for 2 consecutive years.
Is HIMS profitable?
HIMS is not currently profitable on a TTM basis, reporting a net loss of $-13M. Net margin is +5.5%. Investors should monitor for a return to profitability.
What is HIMS's earnings growth rate?
HIMS compound annual EPS growth rates (CAGR): 1-Year: -3.8%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are HIMS's profit margins?
Hims & Hers Health, Inc. net profit margin is +5.5%, operating margin is +4.5%, and gross margin is +73.8%. Margins are within a typical range for the sector. Return on Equity is +25.2%.
Is HIMS growing earnings?
HIMS earnings growth is slowing. Current YoY EPS growth of -3.8% trails the 5-year CAGR of N/A. TTM net income is $-13M.
What was HIMS's best earnings year?
Hims & Hers Health, Inc.'s highest annual net income on record is $128M, achieved in fiscal year 2025. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were HIMS's earnings last quarter?
HIMS's most recent reported quarter was Q1 2026. Net income was $-92M with diluted EPS of $-0.40. For a full breakdown of all quarters, see the quarterly earnings table on this page.